Trial Information
Electronic Study for Anastrozole Pharmacovigilance Evaluation
Inclusion Criteria:
- Post-menopausal Early Invasive Breast Cancer Patients who are under anastrazole
treatment, who have normal renal and hepatic functions.
Exclusion Criteria:
- Metastatic breast cancer patients, previous hormonal therapy, other malignancies.
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
Nejdet Uskent
Investigator Role:
Principal Investigator
Investigator Affiliation:
Kadir Has University Medical School
Authority:
Turkey: Turkish Republic Ministry of Health
Study ID:
ARI-IPEP-0104
NCT ID:
NCT00558168
Start Date:
January 2004
Completion Date:
July 2008
Related Keywords:
- Early Breast Cancer
- Anastrazole
- safety
- early breast cancer
- Breast Neoplasms